Terms: = Liver cancer AND FGFR4, CD334, 2264, ENSG00000160867, P22455, MGC20292, TKF, JTK2 AND Diagnosis
3 results:
1. FGF19-Based Mini Probe Targeting fgfr4 for diagnosis and Surgical Navigation of Hepatocellular Carcinoma.
Cai J; Lian C; Lu Z; Shang Q; Wang L; Han Z; Gu Y
J Med Chem; 2024 Mar; 67(5):3764-3777. PubMed ID: 38385325
[TBL] [Abstract] [Full Text] [Related]
2. Acteoside (Verbascoside): A Prospective Therapeutic Alternative against Hepatocellular Carcinoma by Inhibiting the Expression of AXL, FGFR, BRAF, TIE2 and RAF1 Targets.
Kityania S; Nath R; Nath D; Patra JK; Talukdar AD
Comb Chem High Throughput Screen; 2023; 26(10):1907-1919. PubMed ID: 36321230
[TBL] [Abstract] [Full Text] [Related]
3. Dark and bright side of targeting fibroblast growth factor receptor 4 in the liver.
Gadaleta RM; Moschetta A
J Hepatol; 2021 Dec; 75(6):1440-1451. PubMed ID: 34364916
[TBL] [Abstract] [Full Text] [Related]
